Weather
Upcoming events
Ceny transferowe okiem biegłego rewidenta
Zamknięcie roku podatkowego – lista kontrolna dla działów finansowo-księgowych
Unlocking Life Sciences Potential in Poland
Unlocking Life Sciences Potential in Poland
We invite you to an exclusive executive JLL briefing:
Unlocking Life Sciences Potential in Poland
11:00 AM
JLL Office | 30th floor | myhive Warsaw Spire | Plac Europejski 1, Warsaw
JLL, the Polish Investment and Trade Agency (PAIH), and BIOINMED are proud to co-host this high-level summit bringing together C-suite executives, institutional investors, and thought leaders to examine the critical forces driving life sciences industry’s future.
The convergence of geopolitical shifts, technological breakthroughs, and emerging market dynamics is fundamentally reshaping the global life sciences ecosystem. We invite you to join an exclusive strategic discussion that will define how Europe—and Poland in particular—positions itself at the forefront of this transformation.
Speakers
 Ida StankiewiczBoard Member, Head of Office Tenant Representation |
 George BeatonEMEA Life Sciences Research Lead, JLL
|
 Dr Alexander NuykenEMEA Head of Life Sciences, Leasing Advisory JLL
|
 Marta WiniarskiaPresident of the Board, Managing Director
BioInMed |
 Joanna WilińskaExpert, Investment Support Department PAIH |
Agenda
JLL • The geopolitics of life sciences. What position for Europe in a changing global life sciences landscape? • Focus on AI’s impact on life sciences real estate
PAIH • What propelled Poland into the top 40 most innovative countries globally? • How did Poland build a 150-200k life sciences workforce including 25k scientists? • Which factors attract FDI to Poland, leading CEE country?
BIOINMED • How do organizations like BioInMed facilitate science-business cooperation? • What are the biggest barriers to sector development? • What can we count on in the incoming years? • What distinguishes the research institutes, research consortia and incubators in accelerating innovation and Poland’s competitiveness? • What additional examples of biotech innovations the world should hear about?
